News

2D and 3D floor plans for Type D END UNIT 3-bathroom 3-bedroom Villas in Zulal 1, The Lakes. Zulal 1 has 8 more floor plans for different types of Villas.
New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct a Phase III clinical trial ...
Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia ...
Rhythm Pharmaceuticals is pursuing approval for its rare obesity disorder drug Imcivree in acquired hypothalamic obesity after it showed a 19.8% weight loss in a Phase III trial. The Boston-based ...
A post-hoc analysis of the Phase III VOYAGE 2 (NCT02207244) clinical trial found that Tremfya was associated with greater treatment persistence compared with Taltz (ixekizumab) or Cosentyx ...
14 We retrospectively collected the clinical data from the electronic medical records of patients with stage III resected sole AM across 44 Japanese institutions. All patients underwent wide local ...
"I mean, there's two ways of looking at it, either Edmonton is really good at it, or the rest of the country has become bad at it." ...
In addition, in several predefined analyses on disease activity, OCREVUS IV 600 mg showed clinically meaningful results with the lowest annualised relapse rate (ARR) observed during the double-blind ...
announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 mg dose in people with ...
Chinese biopharmaceutical company Yingli Pharma has obtained US Food and Drug Administration (FDA) approval for a Phase III trial of linperlisib for relapsed/refractory (r/r) peripheral T-cell ...